Lei Duan

Sichuan University — China

Medicine · Health Sciences

30h-index3.4kcitations130works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related Molecular Pathways(34), Microtubule and mitosis dynamics(20), Epigenetics and DNA Methylation(15), Cancer, Hypoxia, and Metabolism(11), Ubiquitin and proteasome pathways(10)

Publications130 total

MVIC: Multi-view Information Collaborative Fusion for Drug-Drug Interaction Prediction
Lecture notes in computer science·2026
Clinical application of preoperative volumetric measurement for interventional precise embolization in the treatment of hypersplenism caused by liver cirrhosis
BMC Surgery·2025Open Access
Supplementary Data from Coinhibition of Aurora Kinase B and SUV4-20H Induces Synthetic Lethality in Wild-type p53-Deficient Cancer Cells
2025Open Access
Figure S1 from Coinhibition of Aurora Kinase B and SUV4-20H Induces Synthetic Lethality in Wild-type p53-Deficient Cancer Cells
2025Open Access
Data from Coinhibition of Aurora Kinase B and SUV4-20H Induces Synthetic Lethality in Wild-type p53-Deficient Cancer Cells
2025Open Access
Figure S7 from Coinhibition of Aurora Kinase B and SUV4-20H Induces Synthetic Lethality in Wild-type p53-Deficient Cancer Cells
2025Open Access
Figure S6 from Coinhibition of Aurora Kinase B and SUV4-20H Induces Synthetic Lethality in Wild-type p53-Deficient Cancer Cells
2025Open Access
Figure S3 from Coinhibition of Aurora Kinase B and SUV4-20H Induces Synthetic Lethality in Wild-type p53-Deficient Cancer Cells
2025Open Access
Supplementary Movie #2 from Coinhibition of Aurora Kinase B and SUV4-20H Induces Synthetic Lethality in Wild-type p53-Deficient Cancer Cells
2025Open Access
Figure S2 from Coinhibition of Aurora Kinase B and SUV4-20H Induces Synthetic Lethality in Wild-type p53-Deficient Cancer Cells
2025Open Access
Figure S4 from Coinhibition of Aurora Kinase B and SUV4-20H Induces Synthetic Lethality in Wild-type p53-Deficient Cancer Cells
2025Open Access
Figure S8 from Coinhibition of Aurora Kinase B and SUV4-20H Induces Synthetic Lethality in Wild-type p53-Deficient Cancer Cells
2025Open Access
Supplementary Table 1 from Coinhibition of Aurora Kinase B and SUV4-20H Induces Synthetic Lethality in Wild-type p53-Deficient Cancer Cells
2025Open Access
Figure S10 from Coinhibition of Aurora Kinase B and SUV4-20H Induces Synthetic Lethality in Wild-type p53-Deficient Cancer Cells
2025Open Access
Figure S5 from Coinhibition of Aurora Kinase B and SUV4-20H Induces Synthetic Lethality in Wild-type p53-Deficient Cancer Cells
2025Open Access
Supplementary Movie #1 from Coinhibition of Aurora Kinase B and SUV4-20H Induces Synthetic Lethality in Wild-type p53-Deficient Cancer Cells
2025Open Access
Figure S9 from Coinhibition of Aurora Kinase B and SUV4-20H Induces Synthetic Lethality in Wild-type p53-Deficient Cancer Cells
2025Open Access
Does the timing matter? The association between childhood adversity and internalizing and externalizing problems from childhood to adolescence and its sex differences
Child Abuse & Neglect·2025· 4 cited
Coinhibition of Aurora Kinase B and SUV4-20H Induces Synthetic Lethality in Wild-type p53-Deficient Cancer Cells
Molecular Cancer Therapeutics·2025· 3 cited
Creb1 Promotes Dormancy Exit and is a Target to Overcome Endocrine Therapy Resistance in ER+ Breast Cancer Cells
SSRN Electronic Journal·2025Open Access
page 1 of 7Next →

Frequent Co-authors

Carl G. Maki(10), Leslie Bernstein(7), Ricardo E. Perez(7), Jane Sullivan‐Halley(6), Hamid Band(5), Jisheng Nie(4), Zhiwei Yan(4), Q. L. Niu(4), Chih‐Ping Chou(3), Manjari Dimri(3), Mayumi Naramura(3), Vimla Band(3), Huiyan Ma(3), Katherine D. Henderson(3), Giske Ursin(3), Dennis Deapen(3), James V. Lacey(3), Cesar F. Ortega-Cava(3), Xiangshan Zhao(3), Sarah Calhoun(3)